Independent provider comparison
Updated October 1, 2026
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
The short decision
Start with Embody if you want the smaller verified initial commitment. Its public catalogue lists one-month compounded semaglutide at $79 and tirzepatide at $129. SnagRx lists $99 and $149 month to month; its matching $69 and $119 floors require twelve months paid up front at $828 or $1,428. Embody separately advertises $69 and $119 on a promotional landing, but we did not verify the final checkout charge or term. Both storefronts are operated by Modern Metabolic Medicine, Inc., use OpenLoop Health and name the same four pharmacies. Neither public record establishes a clinical-quality advantage.
Embody and SnagRx both pay us a commission through our links. They share an operator, but each keeps a separate offer and review record. Commission does not set our scores or this recommendation. How we make money.
Our pick for the smaller verified initial commitment
Embody's catalogue lists one-month compounded semaglutide at $79 and tirzepatide at $129, with care and shipping included.
Its $69 and $119 catalogue equivalents require annual prepayment. A separate promotion advertises those rates monthly, but we did not verify its final checkout term.
Explore Embody's plans Compare Embody plans and care
Consider SnagRx if you prefer its published term-by-term grid
SnagRx shows the amount billed for one, three, six and twelve months before intake and names the same four partner pharmacies as Embody.
Its $69 semaglutide and $119 tirzepatide rates require $828 or $1,428 paid up front. Multi-month purchases are normally non-refundable.
Explore SnagRx's plans Compare SnagRx plans and careSources: Embody current product catalogue · SnagRx pricing and billing terms
Cost
First charge, renewal and commitment
Treatment
Medication, form and approval status
Care
Clinical review and ongoing support
Terms
Cancellation and material cautions
Side by side
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Embody | SnagRx |
|---|---|---|
| Our Score | 7.3/10 | 4.5/10 |
| Headline Price | from $69/mo | published $99/mo; total not verified |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | People who want to compare Embody's published plan menu with its separate monthly promotion and will confirm the exact charge, term and refund rules before paying | Cash-pay buyers who want a published injectable-plan price grid and will compare monthly billing with prepaid terms before checkout |
| Watch out for | Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date. | A small independent review sample: Trustpilot showed 3.1/5 from 7 reviews on October 1, 2026. It cannot establish a typical experience or corroborate the homepage's customer-count claim |
| Ranking | #17 | #33 |
| Get started | Visit Embody | Visit SnagRx |
For Embody's one-month prices, prepaid totals and conflicting billing terms, read the Embody price and payment breakdown.
Trade-offs
Embody's public catalogue lists compounded semaglutide at $79 for one month and $828 paid for twelve months, equal to $69 per month. Its tirzepatide plans are $129 for one month or $1,428 for twelve months, equal to $119 per month. A separate Embody promotion advertises $69 and $119 as flat monthly rates and says its month-to-month option has no contract. We could not verify the final promotional checkout charge or term on September 20, so the catalogue is the confirmed commitment comparison.
SnagRx lists semaglutide at $99 month to month, $267 for three months, $474 for six months and $828 for twelve months. Its tirzepatide terms list $149 month to month, $417 for three months, $774 for six months and $1,428 for twelve months. Multi-month plans are billed once up front and renew for the same length unless cancelled.
The practical difference is the first charge. Embody's verified one-month catalogue prices are $20 lower for either molecule. At the twelve-month floors, both storefronts reach the same $828 semaglutide total and $1,428 tirzepatide total.
Sources: Embody catalogue and term totals · Embody promotional offer · SnagRx plan totals and renewal terms · Complete Embody review · Complete SnagRx review
Modern Metabolic Medicine, Inc. operates both storefronts. Their current public records name OpenLoop Health as the clinical network and the same four 503A pharmacy partners: Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. Neither storefront says which pharmacy will fill an individual prescription before approval.
They remain separate shopping surfaces with different plan displays, checkout paths, terms and Trustpilot profiles. Sharing an operator does not mean a prescription, dose, pharmacy assignment or service outcome will be identical. It does mean that choosing between them is mainly a question of commitment, checkout clarity and storefront-specific evidence rather than choosing between two unrelated medical organizations.
Both menus concern compounded semaglutide and tirzepatide injections. Compounded drugs are not FDA approved, and FDA does not review them for safety, effectiveness or quality before marketing. Public pages do not establish that one storefront's compounded medication is safer or more effective than the other's.
Sources: Embody terms and operating entity · SnagRx terms and operating entity · FDA questions and answers on compounding
Both refund policies say payments are normally final and non-refundable at purchase. Cancelling stops a future renewal but does not return money already paid. Both policies describe a limited provider-initiated medical-disqualification exception, with services already provided deducted from any refund. A twelve-month plan is therefore a committed purchase, not twelve freely cancellable monthly payments.
The storefront-specific review samples are not comparable in size. Embody showed 3.8/5 across 8,121 Trustpilot reviews on September 20, including reviews merged from another profile. SnagRx showed 3.4/5 from 5 reviews on September 22, which is too small for our reputation scoring modifier. Neither rating proves clinical quality.
The BBB profile belongs to Modern Metabolic Medicine, Inc., not one storefront. It showed C, not accredited, with 72 complaints on September 22 and listed Embody, SnagRx and RodeoMeds as alternate names. Those complaints are company-wide and cannot be assigned to either Embody or SnagRx without reviewing each complaint's brand context.
Sources: Embody refund and cancellation policy · SnagRx refund and cancellation policy · Embody on Trustpilot · SnagRx on Trustpilot · Shared operator at the BBB
Yes. Modern Metabolic Medicine, Inc. operates both storefronts, and both name OpenLoop Health plus the same four pharmacy partners. Their offers, checkout paths, terms and Trustpilot profiles remain separate, so compare the exact charge shown by the storefront you use.
Embody has the lower verified one-month catalogue prices: $79 for compounded semaglutide and $129 for tirzepatide, compared with SnagRx at $99 and $149. Their twelve-month floors are the same: $828 for semaglutide and $1,428 for tirzepatide. Embody separately advertises a lower monthly promotion, but we did not verify its final checkout term.
Neither current public catalogue lists brand-name Wegovy or Zepbound. Both comparison records concern compounded semaglutide and tirzepatide injections, which are not FDA-approved products or generic versions of approved brands.
Cancelling either service can stop a future renewal, but both policies normally make amounts already paid non-refundable. Each describes a limited provider-initiated medical-disqualification exception after subtracting services already provided. Read the current policy before paying for a multi-month plan.
Start with Embody if a lower one-month commitment matters. Consider SnagRx only if its storefront and published term grid suit you and you accept the larger prepaid commitment required for its lowest rates. Both pay us a commission, and neither public record proves a clinical-quality advantage.
Keep narrowing the decision
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
More head-to-head comparisons involving Embody and SnagRx.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Embody legit and is SnagRx legit, with the verification evidence behind each answer.
